Research analysts at Canaccord Genuity Group began coverage on shares of TriSalus Life Sciences (NASDAQ:TLSI – Get Free Report) in a research note issued on Thursday, Marketbeat Ratings reports. The brokerage set a “buy” rating and a $12.00 price target on the stock. Canaccord Genuity Group’s target price would suggest a potential upside of 67.60% […]
Analysts at Canaccord Genuity Group assumed coverage on shares of TriSalus Life Sciences (NASDAQ:TLSI – Get Free Report) in a report released on Thursday, MarketBeat.com reports. The brokerage set a “buy” rating and a $12.00 price target on the stock. Canaccord Genuity Group’s price objective would indicate a potential upside of 67.60% from the company’s […]
Analysts at Canaccord Genuity Group began coverage on shares of TriSalus Life Sciences (NASDAQ:TLSI – Get Free Report) in a research note issued to investors on Thursday, Marketbeat reports. The firm set a “buy” rating and a $12.00 price target on the stock. Canaccord Genuity Group’s price objective would suggest a potential upside of 67.60% […]
TriSalus Life Sciences, Inc. (NASDAQ:TLSIW) Sees Large Decrease in Short Interest wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.
TriSalus Life Sciences Announces Commencement of Exchange Offer and Consent Solicitation Relating to Warrants marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.